Close Menu
Home › JP Morgan Healthcare, Day 3: Quidel, Oxford Immunotec, Luminex, GenMark, Bio-Techne, and More

JP Morgan Healthcare, Day 3: Quidel, Oxford Immunotec, Luminex, GenMark, Bio-Techne, and More

Jan 10, 2019
|
Leo O'Connor
|
Monica Heger

SAN FRANCISCO (GenomeWeb) - The 37th annual JP Morgan Healthcare Conference continued here on Wednesday with several life science tools and molecular diagnostics companies presenting before investors. Below are brief reports on the presentations and breakout sessions covered by our team at the conference and in our offices in New York.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
16
Featured Webinar

Using Next-Generation Sequencing to Detect Genomic Mutations in Hematologic Malignancies

Sponsored by
ArcherDX

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Oct
24
Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

What's Popular?

In Molecular Diagnostics

  1. USPSTF Formalizes Slightly Expanded BRCA Screening Recommendations

  2. FDA Stepping Up Actions Against PGx Testing, Forcing Some Labs to Stop Reporting Drug Information

  3. Genomind, NeuroFlow Collaborate to Provide Genetic Testing-Based Mental Health Services

  4. OpGen Progresses on Pipeline of Highly Multiplexed Drug-Resistant Bacteria Tests

    Premium

  5. Cancer Genetics Posts 15 Percent Rise in Q2 Revenues

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.